HWKN vs. AMPH
HWKN (Hawkins, Inc.) and AMPH (Amphastar Pharmaceuticals, Inc.) are both stocks. HWKN operates in Specialty Chemicals (Basic Materials), while AMPH operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, HWKN returned 21.58%/yr vs 2.12%/yr for AMPH. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
HWKN vs. AMPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HWKN achieves a -9.65% return, which is significantly higher than AMPH's -25.54% return. Over the past 10 years, HWKN has outperformed AMPH with an annualized return of 21.58%, while AMPH has yielded a comparatively lower 2.12% annualized return.
HWKN
- 1D
- -0.92%
- 1M
- -7.55%
- 6M
- -1.46%
- YTD
- -9.65%
- 1Y
- -18.98%
- 3Y*
- 41.21%
- 5Y*
- 29.91%
- 10Y*
- 21.58%
- ALL TIME*
- 14.89%
AMPH
- 1D
- -2.16%
- 1M
- 1.53%
- 6M
- -24.73%
- YTD
- -25.54%
- 1Y
- -5.99%
- 3Y*
- -30.98%
- 5Y*
- -0.98%
- 10Y*
- 2.12%
- ALL TIME*
- 9.04%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $8.38M | $7.78M | $11.79M | |
HWKN Hawkins, Inc. | $28.52M | $24.93M | $24.78M |
HWKN vs. AMPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HWKN Hawkins, Inc. | -9.65% | 16.45% | 75.46% | 84.66% | -0.81% | 53.05% | 16.44% | 14.35% | 19.23% | -33.43% |
AMPH Amphastar Pharmaceuticals, Inc. | -25.54% | -27.88% | -39.97% | 120.74% | 20.31% | 15.81% | 4.25% | -3.07% | 3.43% | 4.45% |
Correlation
The correlation between HWKN and AMPH is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.23 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2014 | 0.26 |
The correlation between HWKN and AMPH shifts across timeframes, from 0.16 (1 year) to 0.27 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
HWKN:
$2.67B
AMPH:
$879.21M
HWKN:
$3.87
AMPH:
$1.68
HWKN:
33.11
AMPH:
11.85
HWKN:
2.56
AMPH:
0.63
HWKN:
2.41
AMPH:
1.30
HWKN:
4.87
AMPH:
1.20
HWKN:
$1.11B
AMPH:
$720.53M
HWKN:
$246.70M
AMPH:
$341.13M
HWKN:
$159.50M
AMPH:
$155.96M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HWKN vs. AMPH — Risk / Return Rank
HWKN
AMPH
HWKN vs. AMPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hawkins, Inc. (HWKN) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HWKN | AMPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.45 | ||
| Sortino ratioReturn per unit of downside risk | -0.79 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.04 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | -0.11 | -0.50 |
| Martin ratioReturn relative to average drawdown | -1.14 | -0.19 | -0.95 |
Loading charts...
Drawdowns
HWKN vs. AMPH - Drawdown Comparison
The maximum HWKN drawdown since its inception was -44.76%, smaller than the maximum AMPH drawdown of -74.05%. Use the drawdown chart below to compare losses from any high point for HWKN and AMPH.
Loading charts...
Drawdown Indicators
| HWKN | AMPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.76% | -74.05% | +29.29% |
Max Drawdown (1Y)Largest decline over 1 year | -34.79% | -45.25% | +10.46% |
Max Drawdown (3Y)Largest decline over 3 years | -34.79% | -74.05% | +39.26% |
Max Drawdown (5Y)Largest decline over 5 years | -34.79% | -74.05% | +39.26% |
Max Drawdown (10Y)Largest decline over 10 years | -44.76% | -74.05% | +29.29% |
Current DrawdownCurrent decline from peak | -30.35% | -69.32% | +38.97% |
Average DrawdownAverage peak-to-trough decline | -15.74% | -24.58% | +8.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.63% | 25.36% | -6.73% |
Volatility
HWKN vs. AMPH - Volatility Comparison
The current volatility for Hawkins, Inc. (HWKN) is 10.54%, while Amphastar Pharmaceuticals, Inc. (AMPH) has a volatility of 11.76%. This indicates that HWKN experiences smaller price fluctuations and is considered to be less risky than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HWKN | AMPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.54% | 11.76% | -1.22% |
Volatility (6M)Calculated over the trailing 6-month period | 28.71% | 47.41% | -18.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.31% | 55.13% | -15.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.51% | 45.68% | -9.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.80% | 42.88% | -5.08% |
Dividends
HWKN vs. AMPH - Dividend Comparison
HWKN's dividend yield for the trailing twelve months is around 0.59%, while AMPH has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HWKN Hawkins, Inc. | 0.59% | 0.52% | 0.55% | 0.88% | 1.45% | 1.28% | 1.78% | 2.01% | 2.17% | 2.44% | 1.52% | 2.18% |
Financials
HWKN vs. AMPH - Financials Comparison
This section allows you to compare key financial metrics between Hawkins, Inc. and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HWKN vs. AMPH - Profitability Comparison
HWKN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Hawkins, Inc. reported a gross profit of 74.01M and revenue of 315.68M. Therefore, the gross margin over that period was 23.4%.
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 70.32M and revenue of 171.17M. Therefore, the gross margin over that period was 41.1%.
HWKN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Hawkins, Inc. reported an operating income of 38.67M and revenue of 315.68M, resulting in an operating margin of 12.3%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 13.63M and revenue of 171.17M, resulting in an operating margin of 8.0%.
HWKN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Hawkins, Inc. reported a net income of 28.25M and revenue of 315.68M, resulting in a net margin of 9.0%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 6.42M and revenue of 171.17M, resulting in a net margin of 3.8%.
Frequently Asked Questions
HWKN and AMPH have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMPH has higher volatility (11.76%) compared to HWKN (10.54%). In terms of maximum drawdown, HWKN dropped -44.76% vs AMPH's -74.05%.
AMPH currently has the higher Sharpe Ratio (-0.09 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HWKN and AMPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer